Colossus Minerals Inc

(COLUF)

By |

Profile

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Contact Information

Website: www.atreca.com
Email: greghoyuen@colossusminerals.com
Main Phone: +1 650 595-2595
Address: 500 Saginaw Drive
Address 2: Suite 5600
State: CA
City / Town: Redwood City
Country: USA
Postal Code: 94063

Issuer Information

Exchange: GREY
CEO: John A. Orwin
Employees: 85
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Contact Information

Website: www.atreca.com
Email: greghoyuen@colossusminerals.com
Main Phone: +1 650 595-2595
Address: 500 Saginaw Drive
Address 2: Suite 5600
State: CA
City / Town: Redwood City
Country: USA
Postal Code: 94063

Issuer Information

Exchange: GREY
CEO: John A. Orwin
Employees: 85
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.0003 $ 0. (0.00%)
Last Price 0.0003 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 0.0003
Last Trade Volume 0 52 Wk Hi 0.001 52 Wk Low 0.
Market Cap 8,035 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 26,784,452.00 EPS (TTM) -3.16 PE Ratio N/A Exchange Greys